AM-2232
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C24H20N2O |
| Molar mass | 352.437 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
AM-2232 (1-(4-cyanobutyl)-3-(naphthalen-1-oyl)indole) is a drug that acts as a potent but unselective agonist for the cannabinoid receptors, with a Ki of 0.28 nM at CB1 and 1.48 nM at CB2.[1][2]
In the United States, all CB1 receptor agonists of the 3-(1-naphthoyl)indole class such as AM-2232 are Schedule I Controlled Substances.[3]
See also
[edit]References
[edit]- ↑ US patent 7241799, Makriyannis A, Deng H, "Cannabimimetic indole derivatives", published 2004-11-05, issued 2007-07-10, assigned to University of Connecticut
- ↑ Zagzoog A, Brandt AL, Black T, Kim ED, Burkart R, Patel M, et al. (May 2021). "Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor". Scientific Reports. 11 (1) 10611. Bibcode:2021NatSR..1110611Z. doi:10.1038/s41598-021-90167-w. PMC 8134483. PMID 34012003.
- ↑ : Schedules of controlled substances
 | This cannabinoid related article is a stub. You can help Wikipedia by adding missing information. |